APG Asset Management US’s Royalty Pharma RPRX Stock Holding History

APG Asset Management US’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,872	Closed	-$286K	–	156
2025 Q3	$286K	Hold	7,872	–	–	﹤0.01%	177
2025 Q2	$282K	Hold	7,872	–	–	﹤0.01%	179
2025 Q1	$245K	Hold	7,872	–	–	﹤0.01%	195
2024 Q4	$201K	Buy	+7,872	New	+$209K	﹤0.01%	204
2024 Q3	–	Sell	-102,225	Closed	-$2.68M	–	183
2024 Q2	$2.68M	Sell	102,225 -6,419	-6%	-$178K	0.02%	160
2024 Q1	$3.25M	Buy	108,644 +33,887	+45%	+$999K	0.02%	163
2023 Q4	$2.1M	Buy	+74,757	New	+$2.05M	0.01%	175

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

APG Asset Management US's RPRX Position: Q4 2025 in Review

APG Asset Management US sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 7,872 shares — an estimated $286K sold.

APG Asset Management US first reported a position in RPRX in Q4 2023 and held it in 7 quarters. The position peaked at $3.25M in Q1 2024. 540 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

APG Asset Management US reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
APG Asset Management US sold 7,872 Royalty Pharma shares in Q4 2025, an estimated $286K.
APG Asset Management US first reported a position in Royalty Pharma in Q4 2023 and held it in 7 quarters.
APG Asset Management US's Royalty Pharma position peaked at $3.25M in Q1 2024.
540 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.